1,955 research outputs found
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of cancers, and that SIRT1 deficiency results in genetic instability and tumorigenesis, while overexpression of SIRT1 attenuates cancer formation in mice heterozygous for tumor suppressor p53 or APC. Here, I review these recent findings and discuss the possibility that activation of SIRT1 both extends lifespan and inhibits cancer formation
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Germline mutations of the breast cancer associated gene 1 (BRCA1) predispose women to breast and ovarian cancers. BRCA1 is a large protein with multiple functional domains and interacts with numerous proteins that are involved in many important biological processes/pathways. Mounting evidence indicates that BRCA1 is involved in all phases of the cell cycle and regulates orderly events during cell cycle progression. BRCA1 deficiency, consequently causes abnormalities in the S-phase checkpoint, the G(2)/M checkpoint, the spindle checkpoint and centrosome duplication. The genetic instability caused by BRCA1 deficiency, however, also triggers cellular responses to DNA damage that blocks cell proliferation and induces apoptosis. Thus BRCA1 mutant cells cannot develop further into full-grown tumors unless this cellular defense is broken. Functional analysis of BRCA1 in cell cycle checkpoints, genome integrity, DNA damage response (DDR) and tumor evolution should benefit our understanding of the mechanisms underlying BRCA1 associated tumorigenesis, as well as the development of therapeutic approaches for this lethal disease
Roles of FGF Receptors in Mammalian Development and Congenital Diseases
International audienceFour fibroblast growth factor receptors (FGFR1-4) constitute a family of transmembrane tyrosine kinases that serve as high affinity receptors for at least 22 FGF ligands. Gene targeting in mice has yielded valuable insights into the functions of this important gene family in multiple biological processes. These include mesoderm induction and patterning; cell growth, migration, and differentiation; organ formation and maintenance; neuronal differentiation and survival; wound healing; and malignant transformation. Furthermore, discoveries that mutations in three of the four receptors result in more than a dozen human congenital diseases highlight the importance of these genes in skeletal development. In this review, we will discuss recent progress on the roles of FGF receptors in mammalian development and congenital diseases, with an emphasis on signal transduction pathways
RNAi in mice: a promising approach to decipher gene functions in vivo
International audienceRNA interference (RNAi) is a simple and powerful tool widely used to study gene functions in many species. Vector-based systems using RNA polymerase III promoters have been developed to achieve stable expression of small interfering RNA (siRNA) or small hairpin RNA (shRNA) in mammalian cells. Recent investigations demonstrated that when, combined with the Cre-loxP system, the vector-based RNAi can be used to achieve conditional or tissue specific knockdown of endogenous genes with high efficiency in mice. Here, we review these recent progresses and discuss the advantages, limitations and future development of this emerging technology
RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector
RNA interference (RNAi) is a powerful tool widely used for studying gene function in a number of species. We have previously developed an approach that allows conditional expression of a polymerase III promoter based small hairpin RNA (shRNA) in mice using the Cre-LoxP system. This approach uses a U6 promoter, which is inactive due to the presence of a ploxPneo cassette in the promoter; this promoter can be activated after excision of the neo gene in transgenic mice that express a Cre recombinase transgene. As a proof of principle, we have previously knocked down over 95% of Fgfr2 transcripts in mouse germlines, leading to embryonic lethality, while restricting the knockdown to the progress zone of the limb results in live animals with malformation of digits of both the forelimbs and hindlimbs. We now provide a detailed protocol, including a simplified single-step cloning procedure for vector construction. This method provides a fast yet efficient way to decipher gene functions in vivo in a tissue specific manner
FoxO3 transcription factor and Sirt6 deacetylase regulate LDL-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression
Elevated LDL-cholesterol is a risk factor for the development of cardiovascular disease. Thus, proper control of LDL-cholesterol homeostasis is critical for organismal health. Genetic analysis has identified PCSK9 (proprotein convertase subtilisin/kexin type 9) as a crucial gene in the regulation of LDL-cholesterol via control of LDL receptor degradation. Although biochemical characteristics and clinical implications of PCSK9 have been extensively investigated, epigenetic regulation of this gene is largely unknown. In this work we have discovered that Sirt6, an NAD+-dependent histone deacetylase, plays a critical role in the regulation of the Pcsk9 gene expression in mice. Hepatic Sirt6 deficiency leads to elevated Pcsk9 gene expression and LDL-cholesterol as well. Mechanistically, we have demonstrated that Sirt6 can be recruited by forkhead transcription factor FoxO3 to the proximal promoter region of the Pcsk9 gene and deacetylates histone H3 at lysines 9 and 56, thereby suppressing the gene expression. Also remarkably, overexpression of Sirt6 in high fat diet-fed mice lowers LDL-cholesterol. Overall, our data suggest that FoxO3 and Sirt6, two longevity genes, can reduce LDL-cholesterol levels through regulation of the Pcsk9 gene
Correlated alterations in prostate basal cell layer and basement membrane
Our recent studies revealed that focal basal cell layer disruption (FBCLD)
induced auto-immunoreactions represented a contributing factor for human
prostate tumor progression and invasion. As the basement membrane surrounds and
attaches to the basal cell layer, our current study assessed whether FBCLD would
impact the physical integrity of the associated basement membrane. Paraffin
sections from 25-human prostate tumors were subjected to double
immunohistochemistry to simultaneously elucidate the basal cell layer and the
basement membrane with corresponding biomarkers. The physical integrity of the
basement membrane overlying FBCLD was examined to determine the extent of
correlated alterations. Of a total of 89 FBCLD encountered, 76 (85 %) showed
correlated alterations in the overlying basement membrane, which included
distinct focal disruptions or fragmentations. In the remaining 13 (15%) FBCLD,
the overlying basement membrane showed significant attenuation or reduction of
the immunostaining intensity. The basement membrane in all or nearly all ducts
or acini with p63 positive basal cells was substantially thicker and more
uniform than that in ducts or acini without p63 positive basal cells, and also,
a vast majority of the focal disruptions occurred near basal cells that lack p63
expression. These findings suggest that focal disruptions in the basal cell
layer and alterations in the basement membrane are correlated events and that
the physical and functional status of the basal cells could significantly impact
the physical integrity of the overlying basement membrane. As the degradation of
both the basal cell layer and the basement membrane is a pre-requisite for
prostate tumor invasion or progression, ducts or acini with focally disrupted
basal cell layer and basement membrane are likely at greater risk to develop
invasive lesions. Thus, further elucidation of the specific molecules and
mechanism associated with these events may lead to the development of a more
effective alternative for repeat biopsy to monitor tumor progression and
invasion
- …